STOP T1D

STOP T1D At STOP T1D, we know that early type 1 diabetes detection through screening leads to better outcomes. Please see our website STOPT1DProgram.org for more info.

Our program is led by the Barbara Davis Center for Diabetes at the University of Colorado.

REGISTER NOW for the Barbara Davis Center for Diabetes' 9th Symposium on General Population Screening for T1D to be held...
08/28/2026

REGISTER NOW for the Barbara Davis Center for Diabetes' 9th Symposium on General Population Screening for T1D to be held on November 9-10, 2026 in Denver, Colorado.

The symposium will be accessible in person at the Anschutz Health Sciences Building at the University of Colorado Anschutz Medical Campus or as a hybrid meeting.

The symposium aims to explore the expanding evidence and current international efforts to identify pre-symptomatic T1D, emphasizing the potential benefits such as delayed progression and prevention of complications. Through expert panels and case studies, the event will also address the challenges of monitoring and supporting children with early-stage , as well as the combined screening for both T1D and celiac disease. The discussions will conclude with future directions for screening, highlighting the need for coordinated efforts and policy guidance.

REGISTER: https://redcap.ucdenver.edu/surveys/?s=CNP9K4JE7DRAFD8H

Friendly reminder to health care practitioners! The Barbara Davis Center & Stop T1D's 1-hr interactive discussion on   s...
08/11/2026

Friendly reminder to health care practitioners! The Barbara Davis Center & Stop T1D's 1-hr interactive discussion on screening information is this Thursday, August 13 at 10 AM Pacific | 11 AM Mountain | Noon Central | 1 PM Eastern

Please join us! Register to attend here: stopt1dprogram.org/t1d-screening-zoom

🩺 Health Care Providers! We invite you to join the STOP T1D team from the Barbara Davis Center for Diabetes for an inter...
08/05/2026

🩺 Health Care Providers! We invite you to join the STOP T1D team from the Barbara Davis Center for Diabetes for an interactive 1-hr Zoom-discussion focused on real-world T1D screening implementation.

TOPIC: T1D Screening: Interactive Peer & Expert Discussion
DATE: Thursday, August 13th, 2026
TIME: 11am (MST) / 1pm (EST)

REGISTER for Zoom Call: https://www.stopt1dprogram.org/t1d-screening-zoom

Please note: The session is not a webinar or formal presentation. It is a collaborative discussion where you will have the opportunity to ask questions, hear how others are approaching screening, and learn from peers and experts in the field.

Come ready to discuss topics such as:
⚕️ Talking with individuals and families about the importance of T1D screening
⚕️ Implementing screening workflows in your practice
⚕️ Navigating current screening recommendations and resources
⚕️ Overcoming common barriers and sharing practical solutions

Whether you are just getting started or already screening patients, bring your questions and experiences.

We look forward to learning together!

Sign-up form for "Early T1D Screening Orientation" Zoom call with BDC

🩵 Type 1 Diabetes CME for Health Care Providers - Earn 3.5   credits in 12 clear and applicable modules on early   scree...
08/03/2026

🩵 Type 1 Diabetes CME for Health Care Providers - Earn 3.5 credits in 12 clear and applicable modules on early screenings, timely diagnoses, and age-specific monitoring practices.

1 - Pathophysiology and Natural History of Type 1 Diabetes
2 - Introduction to T1D Screening
3 - Epidemiology of T1D and Target Populations for Screening
4 - NEW: Recognizing and Managing Early-Stage T1D in ED/Acute Care
5 - Screening Methods
6 - Confirmation of Positive Screening Results
7 - Results Notification
8 - Psychological Impact and Engagement
9 - Monitoring and Managing Islet Autoantibody Positive Patients
10 - FDA Approved Treatment for Pre-Symptomatic T1D
11 - Clinical Trials
12 - Implementing Screening and Monitoring into Healthcare Systems

STOPT1Dprogram.org is a program developed independently by the Barbara Davis Center for Diabetes (BarbaraDavisCenter.org). This T1D course is accredited by the Postgraduate Institute for Medicine (PIM) and offers 3.5 CMEs for successful completion.

Learn more and preview Module 1 here: https://www.stopt1dprogram.org/for-hcp (stopt1dprogram. org/for-hcp)

The agenda is out for Barbara Davis Center for Diabetes' 9th Symposium on General Population Screening for T1D to be hel...
07/29/2026

The agenda is out for Barbara Davis Center for Diabetes' 9th Symposium on General Population Screening for T1D to be held on November 9-10, 2026 in Denver, Colorado.

The symposium will be accessible in person at the Anschutz Health Sciences Building at the University of Colorado Anschutz Medical Campus or as a hybrid meeting.

The symposium aims to explore the expanding evidence and current international efforts to identify pre-symptomatic T1D, emphasizing the potential benefits such as delayed progression and prevention of complications. Through expert panels and case studies, the event will also address the challenges of monitoring and supporting children with early-stage , as well as the combined screening for both T1D and celiac disease. The discussions will conclude with future directions for screening, highlighting the need for coordinated efforts and policy guidance.

View the Agenda: https://medschool.cuanschutz.edu/barbara-davis-center-for-diabetes/news-profdev/conferences-events/9th-childhood-diabetes-prevention-symposium---november-9th-10th--2026

 Target Audience: Healthcare professionals including MD, DO, advanced practice providers, nurses, social workers, and dieticians; researchers in the area of screening, monitoring, and prevention of diabetes; lay representatives of patient organizations and representatives of funding agencies.

🗓️ Health Care Providers - Mark your calendars!9th Symposium on General Population Screening for T1DNovember 9-10, 2026 ...
07/16/2026

🗓️ Health Care Providers - Mark your calendars!

9th Symposium on General Population Screening for T1D
November 9-10, 2026

Save the date for the 9th Symposium on General Population Screening for T1D, on November 9-10, 2026, in Denver, Colorado. It will be accessible in person at the Anschutz Health Sciences Building or as a hybrid meeting.

The symposium aims to explore the expanding evidence and current international efforts to identify pre-symptomatic T1D, emphasizing the potential benefits such as delayed progression and prevention of complications. Through expert panels and case studies, the event will also address the challenges of screening, monitoring and supporting children with early-stage T1D. The discussions will conclude with future directions for screening, highlighting the need for coordinated efforts and policy guidance.

TARGET AUDIENCE:
Healthcare professionals including MD, DO, nurses, social workers, and dieticians; researchers in the area of screening, monitoring, and prevention of diabetes; lay representatives of patient organizations and representatives of funding agencies.

Contact [email protected] for any questions about this event. Registration link coming soon!

Is intermittent fasting useful for improving glycemic control and as a weight-management strategy for people living with...
07/14/2026

Is intermittent fasting useful for improving glycemic control and as a weight-management strategy for people living with ?

"Current evidence suggests intermittent fasting is an effective and safe treatment for type 2 diabetes and possibly for prediabetes, whereas data remain insufficient to recommend intermittent fasting for type 1 diabetes and gestational diabetes."

Read more: Intermittent fasting to treat diabetes: time to update clinical practice guidelines https://www.sciencedirect.com/science/article/abs/pii/S2213858726001191

Health Care Providers Take Note: This Dutch   study on the effects of menopausal symptoms on blood glucose levels illust...
07/13/2026

Health Care Providers Take Note: This Dutch study on the effects of menopausal symptoms on blood glucose levels illustrates that biological changes, such as menopause, may require customized approaches to management.

"In a recent Dutch study of 159 women with T1D, approximately two-thirds reported greater glucose instability after ."

"67.4% of the participants reported moderate-to-severe changes in glucose regulation after menopause. Elevated glucose levels were reported to be 41.9%, lower glucose levels by 19.6%, and 38.5% reported no change in blood glucose levels. More than half (approximately 55 %) reported greater glucose variability, 61.6% experienced more hyperglycemic episodes, and 38.5% experienced more hypoglycemic episodes. An increase in the severity of menopausal symptoms was associated with a greater likelihood of changes in blood glucose levels."

Women and Diabetes: Is Care Keeping Pace With Biology? https://www.medscape.com/viewarticle/women-and-diabetes-care-keeping-pace-biology-2026a1000nip

Hormonal changes throughout a woman’s life influence insulin needs, glucose regulation, and cardiovascular risk, highlighting the need for individualized diabetes care.

⚕️ HEALTH CARE PROVIDERS - PLEASE JOIN US! We invite you to participate in an upcoming 1-hr Zoom-call with the team from...
07/09/2026

⚕️ HEALTH CARE PROVIDERS - PLEASE JOIN US! We invite you to participate in an upcoming 1-hr Zoom-call with the team from Barbara Davis Center for Diabetes.

🩸 T1D Screening Orientation: Peer & Expert Discussion
🗓️ Thursday, July 16th
⏰️ 11am (mountain) / 1pm (eastern)

We’ll discuss:
• How to talk about T1D screening with individuals/families
• Navigating the current landscape of T1D screening
• Implementing T1D screening workflows into your practice
• Avoiding common barriers for providers and teams

✅ REGISTER: https://www.stopt1dprogram.org/t1d-screening-orientation

Upon registration you'll receive an email containing the Zoom link and instructions for joining this virtual meeting.

Sign-up form for "Early T1D Screening Orientation" Zoom call with BDC

Health Care Professionals: Let us be your   education hub!Get to know the Barbara Davis Center for Diabetes (BDC) — wher...
07/07/2026

Health Care Professionals: Let us be your education hub!

Get to know the Barbara Davis Center for Diabetes (BDC) — where a wealth of type 1 diabetes information awaits you. Our research is devoted to finding prevention, cure, and the most effective treatments of T1D.

Learn more about BDC at BarbaraDavisCenter.org

BDC Resources :

STOP T1D - An online educational program for individuals, families, , and care providers. Free credits for + Visit our Research Registry to contribute and learn. Go to STOPT1Dprogram.org for more information!

ASK Research Program - A T1D and disease research program which provides no cost type 1 diabetes and celiac disease screenings for U.S. children (12+ months), teens, and adults. Learn more at ASKhealth.org.

Ask the Experts - A program for health care providers and individuals/families living in the United States who screen positive for type 1 diabetes related islet autoantibodies. Together with our national network of clinical and research partners, we provide: Education + support; monitoring resources + guidance; and access to early treatment interventions. Visit us at AskTheExperts.org to get your questions answered.

BDC Conferences & Events - Barbara Davis Center hosts multiple live in-person and hybrid/virtual events each year for HCPs and anyone affected by type 1 diabetes, including families, guardians, and caregivers. See our events page at https://medschool.cuanschutz.edu/barbara-davis-center-for-diabetes/news-profdev/conferences-events

Address

1775 Aurora Court , #A140
Denver, CO
80045

Alerts

Be the first to know and let us send you an email when STOP T1D posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to STOP T1D:

Shortcuts

Share